Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schmierer

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|May 27, 2020
Severe skin reactions associated with cladribine in people with multiple sclerosisM Mateo-Casas, S Reyes, E A O'Toole, et al.
Multiple Sclerosis and Related Disorders|September 26, 2020
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosisA Manzano, I Eskyté, H L Ford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2009
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosisL K Fisniku, D R Altmann, M Cercignani, et al.
Multiple Sclerosis and Related Disorders|May 28, 2021
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.
European Radiology|April 15, 2017
FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?T Campion, R J P Smith, D R Altmann, et al.
Neurology|March 4, 2009
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled studyA D Goodman, H Rossman, A Bar-Or, et al.
Journal of Neurology|December 4, 2003
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cordJ P Mottershead, K Schmierer, M Clemence, et al.
Multiple Sclerosis and Related Disorders|July 11, 2022
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis RegisterR M Middleton, W J Rodgers, J Chataway, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|May 27, 2020
Severe skin reactions associated with cladribine in people with multiple sclerosisM Mateo-Casas, S Reyes, E A O'Toole, et al.
Multiple Sclerosis and Related Disorders|September 26, 2020
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosisA Manzano, I Eskyté, H L Ford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2009
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosisL K Fisniku, D R Altmann, M Cercignani, et al.
Multiple Sclerosis and Related Disorders|May 28, 2021
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.
European Radiology|April 15, 2017
FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?T Campion, R J P Smith, D R Altmann, et al.
Neurology|March 4, 2009
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled studyA D Goodman, H Rossman, A Bar-Or, et al.
Journal of Neurology|December 4, 2003
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cordJ P Mottershead, K Schmierer, M Clemence, et al.
Multiple Sclerosis and Related Disorders|July 11, 2022
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis RegisterR M Middleton, W J Rodgers, J Chataway, et al.
Pageof 5